Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine  Donald G. Lamprecht, PharmD, Anne M.

Published byStina Aamodt Modified over 5 years ago

Similar presentations

Presentation on theme: "A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine  Donald G. Lamprecht, PharmD, Anne M."— Presentation transcript:

1 A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine  Donald G. Lamprecht, PharmD, Anne M. Denham, PharmD, Leslie K. Ruppe, PharmD, Sheila L. Stadler, PharmD, Brittany A. Todd, PharmD  Journal of Clinical Lipidology  Volume 9, Issue 3, Pages (May 2015) DOI: /j.jacl Copyright © Terms and Conditions

2 Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl
Copyright © Terms and Conditions

3 Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl
Copyright © Terms and Conditions

4 Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl
Copyright © Terms and Conditions

5 Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl
Copyright © Terms and Conditions

Download ppt "A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine  Donald G. Lamprecht, PharmD, Anne M."

Similar presentations

2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages 16-18 (March 2003) DOI: 10.1016/S1067-991X(03)70032-7 Copyright.

2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages (March 2003) DOI: /S X(03) Copyright.
Patient request for pharmacist counseling and satisfaction: Automated prescription delivery system versus regular pick-up counter Jan D. Hirsch, PhD Journal.

Patient request for pharmacist counseling and satisfaction: Automated prescription delivery system versus regular pick-up counter Jan D. Hirsch, PhD Journal.
Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,

Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,
Donald Gardenier, Amelia Schreibman, Rosemary Henrich 

Donald Gardenier, Amelia Schreibman, Rosemary Henrich 
A clinician's guide to statin drug-drug interactions

A clinician's guide to statin drug-drug interactions
Should Antibiotics Be Given Routinely to Prevent Joint Implant Infections in Patients Undergoing Dental Procedures?  Donald Gardenier  The Journal for.

Should Antibiotics Be Given Routinely to Prevent Joint Implant Infections in Patients Undergoing Dental Procedures?  Donald Gardenier  The Journal for.
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels†  Eli.

Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels†  Eli.
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,
An assessment by the Statin Cognitive Safety Task Force: 2014 update

An assessment by the Statin Cognitive Safety Task Force: 2014 update
An assessment by the Statin Muscle Safety Task Force: 2014 update

An assessment by the Statin Muscle Safety Task Force: 2014 update
An assessment by the Statin Liver Safety Task Force: 2014 update

An assessment by the Statin Liver Safety Task Force: 2014 update
Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.

Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients  Evan Stein, MD, Harold Bays, MD, Michael Koren,

Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients  Evan Stein, MD, Harold Bays, MD, Michael Koren,
A review of PCSK9 inhibition and its effects beyond LDL receptors

A review of PCSK9 inhibition and its effects beyond LDL receptors
Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial  Hannah M. Renner,

Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial  Hannah M. Renner,
Donald Gardenier, Amelia Schreibman, Rosemary Henrich 

Donald Gardenier, Amelia Schreibman, Rosemary Henrich 
Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,

Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,
Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.

Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C- III levels in patients from the MARINE and ANCHOR studies  Christie.

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C- III levels in patients from the MARINE and ANCHOR studies  Christie.
Predictors of first-year statin medication discontinuation: A cohort study  Heli Halava, MD, Risto Huupponen, MD, PhD, Jaana Pentti, BSc, Mika Kivimäki,

Predictors of first-year statin medication discontinuation: A cohort study  Heli Halava, MD, Risto Huupponen, MD, PhD, Jaana Pentti, BSc, Mika Kivimäki,

Similar presentations

Ads by Google